Accueil   Diary - News   All news Innate Pharma : Preclinical data published in "Cancer Research"

Innate Pharma : Preclinical data published in “Cancer Research”

Innate Pharma newsletterInnate Pharma SA (the “Company” - Euronext Paris: FR0010331421 – IPH), the innate immunity company developing first-in-class therapeutic antibodies for cancer and inflammatory diseases, today announced that a peer-reviewed scientific article describing IPH4102 and results of preclinical efficacy studies was published online in Cancer Research, a journal of the American Association for Cancer Research.


Read the press release